Zobrazeno 1 - 10
of 335
pro vyhledávání: '"Plaseska-Karanfilska Dijana"'
Autor:
Kiprijanovska Sanja, Stefanovska Emilija Sukarova, Noveski Predrag, Ivanova Viktorija Chaloska, Plaseska-Karanfilska Dijana
Publikováno v:
The EuroBiotech Journal, Vol 1, Iss 2, Pp 117-125 (2017)
Hepatitis C virus (HCV) infection becomes a major public health problem and leading cause of chronic liver disease and liver failure. Pegylated interferon-alfa and ribavirin are currently the standard treatment for chronic hepatitis C (CHC). It is in
Externí odkaz:
https://doaj.org/article/f99b4f7673af4f42b38144b2040f7d5b
Autor:
Maleva Kostovska I., Jakimovska M., Kubelka-Sabit K., Karadjozov M., Arsovski A., Stojanovska L., Plaseska-Karanfilska Dijana
Publikováno v:
Balkan Journal of Medical Genetics, Vol 18, Iss 1, Pp 47-54 (2015)
Clinical importance of the most common CHEK2 (IVS2+1 G>A, 1100delС, I157T and del5395) and NBN (R215W and 657del5) gene mutations for breast cancer development in Macedonian breast cancer patients is unknown. We performed a case-control study includ
Externí odkaz:
https://doaj.org/article/22a031bbf808430f8d1c41c821b359c1
Autor:
Plaseska-Karanfilska Dijana, Sukarova-Stefanovska E, Kocheva S, Maleva I, Noveski P, Kiprijanovska S, Stankova K, Dimcev P, Madjunkov M, Madjunkova S
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 39-43 (2012)
Externí odkaz:
https://doaj.org/article/0f0edd8ebc9744a392b999e5d64cdef1
Autor:
Plaseska-Karanfilska Dijana, Atanasovska B, Bozhinovski G, Chakalova L, Kocheva S, Karanfilski O
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 61-65 (2012)
A high-quality hemoglobinopathy diagnosis is based on the results of a number of tests including assays for molecular identification of causative mutations. We describe the current diagnostic strategy for the identification of b-thalassemias and hemo
Externí odkaz:
https://doaj.org/article/1aa4a8252d9245bd9c8ee20f0d57db70
Autor:
Plaseska-Karanfilska Dijana
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 9-12 (2012)
Externí odkaz:
https://doaj.org/article/45aaac5cf6f54b2497f110d05435ff64
Autor:
Plaseska-Karanfilska Dijana, Maleva I, Madjunkova S, Bozhinovski G, Smickova E, Kondov G, Spiroski Z, Arsovski A
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 81-85 (2012)
The most significant and well characterized genetic risk factors for breast and/or ovarian cancer are germline mutations in the BRCA1 and BRCA2 genes. The BRCA1 and BRCA2 gene mutations strikingly increase breast cancer risk, suggesting that polymorp
Externí odkaz:
https://doaj.org/article/625d29c023cb4136b2942eaf334e3762
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 31-34 (2012)
Externí odkaz:
https://doaj.org/article/d39f0512527d47fc9ec1a2096565fb7f
Autor:
Dimitrovska, Maja1 (AUTHOR) maja.c.dimitrovska@gmail.com, Plaseska-Karanfilska, Dijana2 (AUTHOR), Gogusev, Jean K.3 (AUTHOR), Milenkovic, Tatjana1 (AUTHOR), Bozhinovski, Gjorgji2 (AUTHOR), Dimitrovski, Cedomir4 (AUTHOR)
Publikováno v:
Clinical Medicine Insights: Endocrinology & Diabetes. 10/21/2024, p1-7. 7p.
Autor:
Plaseska-Karanfilska Dijana, Kiprijanovska S, Sukarova-Stefanovska E, Noveski P, Polenakovic M, Chalovska V
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 67-69 (2012)
Hepatitis C virus (HCV) is a major public health problem. It is a leading cause of chronic liver disease and the most common indication for liver transplantation. The therapy for eradication of HCV infection is successful in only 50.0-80.0% of patien
Externí odkaz:
https://doaj.org/article/9cc2294eab0749c7b3d4e71180c0a34d
Autor:
Plaseska-Karanfilska Dijana, Popovska-Jankovic K, Noveski P, Chakalova L, Petrusevska G, Kubelka K
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 87-89 (2012)
MicroRNAs (miRNAs) are small [~21 nucleotide (nt)] non coding RNAs (ncRNAs) that regulate gene expression posttranscriptionally. About 3.0% of human genes encode for miRNAs, and up to 30.0% of human protein coding genes may be regulated by miRNAs. Cu
Externí odkaz:
https://doaj.org/article/f93ad8f9c9244eadbd64a35e0f190dda